Please login to the form below

Not currently logged in

EFPIA director general Richard Bergström resigns

Will remain in the role until a successor has been selected

EFPIA Richard BergstromRichard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his post.

Described by the EFPIA's president Joe Jimenez as “the voice of the pharmaceutical industry in Europe for the past five years”, Bergström was appointed as director general in 2011, succeeding Brian Ager.

Bergström brought almost 20 years of pharmaceutical industry experience to the role, having started out as a pharmacist before holding a number of senior positions in regulatory affairs for Novartis and Roche.

He had been a member of the EFPIA board for a number of years prior to taking on the top job, joining the association from Swedish research-based pharmaceutical association LIF where he served as its director general.

Commenting on his decision to resign, Bergström said: “I am proud to leave EFPIA at a time when we have developed policies that promote innovation and patient access, such as through the focus on outcomes and on adaptive pathways to speed up the development of new medicines.

“After 15 fantastic years leading industry associations in Sweden and in Brussels, it is time for me to take on a fresh challenge.”

Led by Bergström, the search for his replacement is underway, and he has committed to continuing on as director general until a successor has been identified.

2nd September 2016

From: Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...